The Biomerica COVID-19 IgG/IgM Rapid Test is a qualitative rapid immunoassay for the detection of IgG and IgM antibodies to SARS-CoV-2 in whole blood, serum or plasma specimens. The specimen reacts with SARS-CoV-2 coupled gold conjugate and then reacts with anti-human IgM and/or anti-human IgG in the test line region if the specimen contains antibodies directed to SARS-CoV-2.